Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Stein, CA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 103 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vilenchik, M; Benimetsky, L; Kolbanovsky, A; Miller, P; Stein, CA
      Evidence for higher-order structure formation by the c-myb 18-mer phosphorothioate antisense (codons 2-7) oligodeoxynucleotide: Potential relationship to antisense c-myb inhibition

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    2. Stein, CA
      Antisense that comes naturally

      NATURE BIOTECHNOLOGY
    3. Berton, M; Turelli, P; Trono, D; Stein, CA; Allemann, E; Gurny, R
      Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles

      PHARMACEUTICAL RESEARCH
    4. Lebedeva, I; Stein, CA
      Antisense oligonucleotides: Promise and reality

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    5. Koehn, RK; Rossi, J; Stein, CA
      In defense of antisense

      SCIENCE
    6. Su, ZZ; Lebedeva, IV; Gopalkrishnan, RV; Goldstein, NI; Stein, CA; Reed, JC; Dent, P; Fisher, PB
      A combinatorial approach for selectively inducing programmed cell death inhuman pancreatic cancer cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    7. Benimetskaya, L; Miller, P; Benimetsky, S; Maciaszek, A; Guga, P; Beaucage, SL; Wilk, A; Grajkowski, A; Halperin, AL; Stein, CA
      Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: Relationship to the decreased viability of T24 bladder andPC3 prostate cancer cells

      MOLECULAR PHARMACOLOGY
    8. Lebedeva, I; Raffo, A; Rando, R; Ojwang, J; Cossum, P; Stein, CA
      Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides

      JOURNAL OF UROLOGY
    9. Stein, CA
      The experimental use of antisense oligonucleotides: a guide for the perplexed

      JOURNAL OF CLINICAL INVESTIGATION
    10. Koziolkiewicz, M; Gendaszewska, E; Maszewska, M; Stein, CA; Stec, WJ
      The mononucleotide-dependent, nonantisense mechanism of action of phosphodiester and phosphorothioate oligonucleotides depends upon the activity of an ecto-5 '-nucleotidase

      BLOOD
    11. Lebedeva, IV; Stein, CA
      Antisense oligonucleotides in cancer - Recent advances

      BIODRUGS
    12. Stein, CA
      Evaluating the mechanism of action of antiproliferative antisense drugs: Aconvergence of views?

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    13. Ma, M; Benimetskaya, L; Lebedeva, I; Dignam, J; Takle, G; Stein, CA
      Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences

      NATURE BIOTECHNOLOGY
    14. Stein, CA
      Is irrelevant cleavage the price of antisense efficacy?

      PHARMACOLOGY & THERAPEUTICS
    15. Benimetskaya, L; Tonkinson, J; Stein, CA
      Determination of cellular internalization of fluoresceinated oligonucleotides

      ANTISENSE TECHNOLOGY, PT A
    16. Lebedeva, IV; Stein, CA
      Antisense downregulation of the apoptosis-related Bcl-2 and Bcl-xL proteins: A new approach to cancer therapy

      MOLECULAR BIOLOGY
    17. Lebedeva, I; Rando, R; Ojwang, J; Cossum, P; Stein, CA
      Bcl-xL in prostate cancer cells: Effects of overexpression and down-regulation on chemosensitivity

      CANCER RESEARCH
    18. Krieg, AM; Stein, CA
      Antisense and nucleic acid-based therapeutics: The next millennium

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    19. Simon, AD; Giedd, KN; Schwartz, A; Wang, W; Sun, J; Chen, HJ; Marboe, C; Stein, CA; Rabbani, LE
      Porous balloon delivery of S-dC28 does not prevent restenosis in the porcine coronary artery model of balloon injury

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    20. Lee, M; Simon, AD; Stein, CA; Rabbani, LE
      Antisense strategies to inhibit restenosis

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    21. Lebedeva, IV; Stein, CA
      Bcl-xL-directed oligonucleotides in prostate and bladder carcinoma cell lines

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    22. Stein, CA
      Hybridization prediction gets to first base

      NATURE BIOTECHNOLOGY
    23. Stein, CA
      Keeping the biotechnology of antisense in context

      NATURE BIOTECHNOLOGY
    24. Yamamoto, H; Soh, JW; Monden, T; Klein, MG; Zhang, LM; Shirin, H; Arber, N; Tomita, N; Schieren, I; Stein, CA; Weinstein, IB
      Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis

      CLINICAL CANCER RESEARCH
    25. Berton, M; Allemann, E; Stein, CA; Gurny, R
      Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    26. Stein, CA
      Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    27. Stein, CA
      Mechanisms of action of taxanes in prostate cancer

      SEMINARS IN ONCOLOGY
    28. Miao, HQ; Elkin, M; Aingorn, E; Ishai-Michaeli, R; Stein, CA; Vlodavsky, I
      Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

      INTERNATIONAL JOURNAL OF CANCER
    29. DeLaughter, J; Stein, S; Stein, CA
      Extraction of a lithospheric cooling signal from oceanwide geoid data

      EARTH AND PLANETARY SCIENCE LETTERS
    30. Khaled, Z; Ho, YY; Benimetskaya, L; Deckelbaum, RJ; Stein, CA
      omega-6 polyunsaturated fatty acid-stimulated cellular internalization of phosphorothioate oligodeoxynucleotides - Evidence for protein kinase C-zetadependency

      BIOCHEMICAL PHARMACOLOGY
    31. Lebedeva, IV; Stein, CA
      Phosphorothioate oligodeoxynucleotides as inhibitors of gene expression: Antisense and non-antisense effects

      APPLICATIONS OF ANTISENSE THERAPIES TO RESTENOSIS
    32. Wyatt, JR; Stein, CA
      Oligonucleotides containing the G-quartet sequence motif

      APPLICATIONS OF ANTISENSE THERAPIES TO RESTENOSIS
    33. WANG WZ; CHEN HJ; SUN J; BENIMETSKAYA L; SCHWARTZ A; CANNON P; STEIN CA; RABBANI LE
      A COMPARISON OF GUANOSINE-QUARTET INHIBITORY EFFECTS VERSUS CYTIDINE HOMOPOLYMER INHIBITORY EFFECTS ON RAT NEOINTIMAL FORMATION

      Antisense & nucleic acid drug development
    34. STEIN CA
      HOW TO DESIGN AN ANTISENSE OLIGODEOXYNUCLEOTIDE EXPERIMENT - A CONSENSUS APPROACH

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    35. CHEN HJ; WANG W; SCHWARTZ A; LIANG D; SUN J; STEIN CA; RABBANI LE
      TIME-COURSE OF CYTIDINE HOMOPOLYMER NON-SEQUENCE-SPECIFIC INHIBITORY EFFECTS ON IN-VIVO RAT NEOINTIMAL FORMATION

      Journal of investigative medicine
    36. LIU WY; RUBIN MA; OMENE C; LEDERMAN S; STEIN CA
      FAS LIGAND IS CONSTITUTIVELY SECRETED BY PROSTATE-CANCER CELLS IN-VITRO

      Clinical cancer research
    37. Benimetskaya, L; Takle, GB; Vilenchik, M; Lebedeva, I; Miller, P; Stein, CA
      Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides

      NUCLEIC ACIDS RESEARCH
    38. YAKUBOV LA; KIT YY; RICHTER VA; ANDREEVA AY; KARAMYSHEV VN; STEIN CA; VLASSOV VV
      THE EXTRACELLULAR DOMAIN OF CD4 RECEPTOR POSSESSES A PROTEIN-KINASE ACTIVITY

      FEBS letters
    39. WANG WZ; CHEN HJ; SCHWARTZ A; CANNON PJ; STEIN CA; RABBANI LE
      INHIBITORY NONSEQUENCE-SPECIFIC EFFECTS OF CYTIDINE HOMOPOLYMERS ON IN-VIVO NEOINTIMAL FORMATION

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    40. STEIN CA
      CONTROVERSIES IN THE CELLULAR PHARMACOLOGY OF OLIGODEOXYNUCLEOTIDES

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    41. WANG WZ; CHEN HJ; WARSHOFSKY M; SCHWARTZ A; STEIN CA; RABBANI LE
      EFFECTS OF S-DC28 ON VASCULAR SMOOTH-MUSCLE CELL-ADHESION AND PLASMINOGEN-ACTIVATOR PRODUCTION

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    42. LEDERMAN S; SULLIVAN G; BENIMETSKAYA L; LOWY I; LAND K; KHALED Z; CLEARY AM; YAKUBOV L; STEIN CA
      POLYDEOXYGUANINE MOTIFS IN A 12-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE AUGMENT BINDING TO THE V3LOOP OF HIV-I GP-120 AND POTENCY OF HIV-1 INHIBITION IN DEPENDENTLY OF G-TETRAD FORMATION (VOL 6, PG 286, 1996)

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    43. KRIEG AM; STEIN CA
      UNDERSTANDING THE CHALLENGES OF NUCLEIC-ACID THERAPY

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    44. BENIMETSKAYA L; LOIKE J; STEIN CA
      OLIGONUCLEOTIDES - EXTRAPOLATING FROM IN-VITRO TO IN-VIVO - REPLY

      Nature medicine
    45. BENIMETSKAYA L; LOIKE JD; KHALED Z; LOIKE G; SILVERSTEIN SC; CAO L; KHOURY JE; CAI TQ; STEIN CA
      MAC-1 (CDLLB CD18) IS AN OLIGODEOXYNUCLEOTIDE-BINDING PROTEIN/

      Nature medicine
    46. LIU QY; STEIN CA
      TAXOL AND ESTRAMUSTINE-INDUCED MODULATION OF HUMAN PROSTATE-CANCER CELL APOPTOSIS VIA ALTERATION IN BCL-X(L) AND BAK EXPRESSION

      Clinical cancer research
    47. SHERWOOD RA; MARSDEN JT; STEIN CA; SOMASUNDARAM S; AITKEN C; OXFORD JS; MENZIES IS; BJARNASON I
      INTRAINDIVIDUAL VARIATION IN SERUM AZT CONCENTRATION IS NOT RELATED TO INTESTINAL-ABSORPTION OR SMALL-INTESTINAL INFLAMMATORY CHANGES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED SUBJECTS

      Antiviral chemistry & chemotherapy
    48. CIAPPI S; AZZI A; STEIN CA; DESANTIS R; OXFORD JS
      ISOLATION OF INFLUENZA A(H3N2) VIRUS WITH O-]D PHASE VARIATION

      Research in virology
    49. WANG W; CHEN HJ; YAZDANI S; CAMPBELL M; SCHWARTZ A; STEIN CA; RABBANI LRE
      LENGTH-DEPENDENCY OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES ON THE NON-SEQUENCE SPECIFIC INHIBITORY EFFECTS OF IN-VITRO VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND MIGRATION

      Journal of the American College of Cardiology
    50. BENIMETSKAYA L; BERTON M; KOLBANOVSKY A; BENIMETSKY S; STEIN CA
      FORMATION OF A G-TETRAD AND HIGHER-ORDER STRUCTURES CORRELATES WITH BIOLOGICAL-ACTIVITY OF THE REIA (NF-KAPPA-B P65) ANTISENSE OLIGODEOXYNUCLEOTIDE

      Nucleic acids research
    51. STEIN CA; STEIN S
      ESTIMATION OF LATERAL HYDROTHERMAL FLOW DISTANCE FROM SPATIAL VARIATIONS IN OCEANIC HEAT-FLOW

      Geophysical research letters
    52. STEIN S; STEIN CA
      GEOSCIENCE - SEA-FLOOR DEPTH AND THE LAKE-WOBEGON EFFECT

      Science
    53. ROCKWELL P; OCONNOR WJ; KING K; GOLDSTEIN NI; ZHANG LM; STEIN CA
      CELL-SURFACE PERTURBATIONS OF THE EPIDERMAL GROWTH-FACTOR AND VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTORS BY PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES

      Proceedings of the National Academy of Sciences of the United Statesof America
    54. STEIN CA; KRIEG A
      ANTISENSE IS HERE TO STAY

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    55. LEDERMAN S; SULLIVAN G; BENIMETSKAYA L; LOWY I; LAND K; KHALED Z; CLEARY AM; YAKUBOV L; STEIN CA
      POLYDEOXYGUANINE MOTIFS IN A 12-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE AUGMENT BINDING TO THE V3 LOOP OF HIV-1 GP120 AND POTENCY OF HIV-1 INHIBITION INDEPENDENTLY OF G-TETRAD FORMATION

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    56. ECKSTEIN F; KRIEG AM; STEIN CA; AGRAWAL S; BEAUCAGE S; COOK PD; CROOKE S; GAIT MJ; GEWIRTZ A; HELENE C; MILLER P; NARAYANAN R; NICOLIN A; NIELSEN P; OHTSUKA E; SELIGER H; STEC W; TIDD D; WAGNER R; ZON J
      ON THE QUALITY-CONTROL OF ANTISENSE OLIGONUCLEOTIDES

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    57. STEIN CA; KRIEG A
      5 YEARS OF ANTISENSE - MOVING FORWARD INTO OUR 6TH YEAR WITH AN EXPANDED EDITORIAL FOCUS

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    58. WAN WZ; CHEN HJ; ZHANG LM; SCHWARTZ A; STEIN CA; RABBANI LE
      FIBRONECTIN AND LAMININ ATTENUATE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE SEQUENCE-INDEPENDENT INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-ADHESION

      Journal of investigative medicine
    59. STEIN CA
      THE REAL KAPOSIS-SARCOMA AND SURREAL ANTISENSE - REPLY

      Nature medicine
    60. STEIN CA
      EXPLOITING THE POTENTIAL OF ANTISENSE - BEYOND PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES (VOL 3, PG 319, 1996)

      Chemistry & biology
    61. STEIN CA
      EXPLOITING THE POTENTIAL OF ANTISENSE - BEYOND PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES

      Chemistry & biology
    62. LOIKE JD; BENIMETSKAYA L; LOIKE G; SOLECKI DJ; SILVERSTEIN SC; STEIN CA
      ALPHA(M)BETA(2) INTEGRIN MEDIATES THE BINDING AND INTERNALIZATION OF OLIGODEOXYNUCLEOTIDES

      Molecular biology of the cell
    63. STEIN CA; NARAYANAN R
      ANTISENSE OLIGODEOXYNUCLEOTIDES - INTERNALIZATION, COMPARTMENTALIZATION AND NON-SEQUENCE SPECIFICITY

      Perspectives in drug discovery and design
    64. TONKINSON JL; STEIN CA
      ANTISENSE OLIGODEOXYNUCLEOTIDES AS CLINICAL THERAPEUTIC AGENTS

      Cancer investigation
    65. KHALED Z; BENIMETSKAYA L; ZELTSER R; KHAN T; SHARMA HW; NARAYANAN R; STEIN CA
      MULTIPLE MECHANISMS MAY CONTRIBUTE TO THE CELLULAR ANTIADHESIVE EFFECTS OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES

      Nucleic acids research
    66. STEIN CA
      PHOSPHOROTHIOATE ANTISENSE OLIGODEOXYNUCLEOTIDES - QUESTIONS OF SPECIFICITY

      Trends in biotechnology
    67. GEWIRTZ AM; STEIN CA; GLAZER PM
      FACILITATING OLIGONUCLEOTIDE DELIVERY - HELPING ANTISENSE DELIVER ON ITS PROMISE - COMMENTARY

      Proceedings of the National Academy of Sciences of the United Statesof America
    68. WANG WZ; CHEN HJ; SCHWARTZ A; CANNON PJ; STEIN CA; RABBANI LE
      SEQUENCE-INDEPENDENT INHIBITION OF IN-VITRO VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION, MIGRATION, AND IN-VIVO NEOINTIMAL FORMATION BY PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES

      The Journal of clinical investigation
    69. CHEN HJ; WANG WZ; SIMON AD; SCHWARTZ A; CANNON PJ; STEIN CA; RABBANI LE
      PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE SEQUENCE-INDEPENDENT INHIBITIONOF IN-VIVO NEOINTIMAL SMOOTH-MUSCLE CELL-PROLIFERATION AFTER VASCULARINJURY

      Circulation
    70. STEIN CA
      ANTITUMOR EFFECTS OF ANTISENSE PHOSPHOROTHIOATE C-MYC OLIGODEOXYNUCLEOTIDES - A QUESTION OF MECHANISM

      Journal of the National Cancer Institute
    71. STEIN CA
      DOES ANTISENSE EXIST

      Nature medicine
    72. STEIN CA; KHAN TM; KHALED Z; TONKINSON JL
      CELL-SURFACE BINDING AND CELLULAR INTERNALIZATION PROPERTIES OF SURAMIN, A NOVEL ANTINEOPLASTIC AGENT

      Clinical cancer research
    73. KHALED Z; RIDEOUT D; ODRISCOLL KR; PETRYLAK D; CACACE A; PATEL R; CHIANG LC; ROTENBERG S; STEIN CA
      EFFECTS OF SURAMIN-RELATED AND OTHER CLINICALLY THERAPEUTIC POLYANIONS ON PROTEIN-KINASE-C ACTIVITY

      Clinical cancer research
    74. KRIEG AM; STEIN CA
      PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES - ANTISENSE OR ANTI-PROTEIN

      Antisense research and development
    75. SU ZZ; YEMUL S; STEIN CA; FISHER PB
      C-FOS IS A POSITIVE REGULATOR OF CARCINOGEN ENHANCEMENT OF ADENOVIRUSTRANSFORMATION

      Oncogene
    76. BENIMETSKAYA L; TONKINSON JL; KOZIOLKIEWICZ M; KARWOWSKI B; GUGA P; ZELTSER R; STEC W; STEIN CA
      BINDING OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TO BASIC FIBROBLASTGROWTH-FACTOR, RECOMBINANT SOLUBLE CD4, LAMININ AND FIBRONECTIN IS P-CHIRALITY INDEPENDENT

      Nucleic acids research
    77. HENDERSON GB; STEIN CA
      5'-CHOLESTERYL-PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES - POTENT INHIBITION OF METHOTREXATE TRANSPORT AND ANTAGONISM OF METHOTREXATE TOXICITYIN CELLS CONTAINING THE REDUCED-FOLATE CARRIER

      Nucleic acids research
    78. RACE E; STEIN CA; WIGG MD; BAKSH A; ADDAWE M; FREZZA P; OXFORD JS
      A MULTISTEP PROCEDURE FOR THE CHEMICAL INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS FOR USE AS AN EXPERIMENTAL VACCINE

      Vaccine
    79. RICHARDSON WP; STEIN S; STEIN CA; ZUBER MT
      GEOID DATA AND THERMAL STRUCTURE OF THE OCEANIC LITHOSPHERE

      Geophysical research letters
    80. SHARMA HW; SOKOLOSKI JA; PEREZ JR; MALTESE JY; SARTORELLI AC; STEIN CA; NICHOLS G; KHALED Z; TELANG NT; NARAYANAN R
      DIFFERENTIATION OF IMMORTAL CELLS INHIBITS TELOMERASE ACTIVITY

      Proceedings of the National Academy of Sciences of the United Statesof America
    81. GUVAKOVA MA; YAKUBOV LA; VLODAVSKY I; TONKINSON JL; STEIN CA
      PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES BIND TO BASIC FIBROBLAST GROWTH-FACTOR, INHIBIT ITS BINDING TO CELL-SURFACE RECEPTORS, AND REMOVE ITFROM LOW-AFFINITY BINDING-SITES OIL EXTRACELLULAR-MATRIX

      The Journal of biological chemistry
    82. BISHOP WP; LIN J; STEIN CA; KRIEG AM
      INTERRUPTION OF A TRANSFORMING GROWTH-FACTOR-ALPHA AUTOCRINE LOOP IN CACO-2 CELLS BY ANTISENSE OLIGODEOXYNUCLEOTIDES

      Gastroenterology
    83. WANG W; CHEN HJ; ZHANG LM; WACHTEL C; SCHWARTZ A; STEIN CA; RABBANI LE
      SEQUENCE INDEPENDENT INHIBITION OF SMOOTH-MUSCLE CELL-PROLIFERATION BY PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES

      Circulation
    84. WANG WZ; BENIMETSKAYA L; CHEN HJ; SCHWARTZ A; STEIN CA; RABBANI LE
      PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES INHIBIT VASCULAR SMOOTH-MUSCLECELL FIBRINOLYSIS AND MIGRATION

      Circulation
    85. STEIN CA; STEIN S
      CONSTRAINTS ON HYDROTHERMAL HEAT-FLUX THROUGH THE OCEANIC LITHOSPHEREFROM GLOBAL HEAT-FLOW

      JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH
    86. TONKINSON JL; GUVAKOVA M; KHALED Z; LEE J; YAKUBOV L; MARSHALL WS; CARUTHERS MH; STEIN CA
      CELLULAR PHARMACOLOGY AND PROTEIN-BINDING OF PHOSPHOROMONOTHIOATE ANDPHOSPHORODITHIOATE OLIGODEOXYNUCLEOTIDES - A COMPARATIVE-STUDY

      Antisense research and development
    87. STEIN CA; KRIEG AM
      PROBLEMS IN INTERPRETATION OF DATA DERIVED FROM IN-VITRO AND IN-VIVO USE OF ANTISENSE OLIGODEOXYNUCLEOTIDES

      Antisense research and development
    88. LAROCCA RV; COOPER MR; DANESI R; STEIN CA; MYERS CE
      SURAMIN THERAPY FOR MALIGNANT THYMOMA - A CASE-REPORT

      European journal of cancer
    89. TONKINSON JL; STEIN CA
      PATTERNS OF INTRACELLULAR COMPARTMENTALIZATION, TRAFFICKING AND ACIDIFICATION OF 5'-FLUORESCEIN LABELED PHOSPHODIESTER AND PHOSPHOROTHIOATEOLIGODEOXYNUCLEOTIDES IN HL-60 CELLS

      Nucleic acids research
    90. ARCHAMBAULT D; STEIN CA; COHEN JS
      PHOSPHOROTHIOATE OLIGONUCLEOTIDES INHIBIT THE REPLICATION OF LENTIVIRUSES AND TYPE-D RETROVIRUSES, BUT NOT THAT OF TYPE-C RETROVIRUSES

      Archives of virology
    91. STEIN CA; LEVANTIS P; OXFORD JS
      SEQUENCE-ANALYSIS OF PROVIRAL HIV RT AMPLIFIED DIRECTLY BY A SEMIQUANTITATIVE TECHNIQUE FROM AZT TREATED PATIENTS

      Journal of medical virology
    92. STEIN CA; STEIN S
      COMPARISON OF PLATE AND ASTHENOSPHERIC FLOW MODELS FOR THE THERMAL EVOLUTION OF OCEANIC LITHOSPHERE

      Geophysical research letters
    93. PELAYO AM; STEIN S; STEIN CA
      ESTIMATION OF OCEANIC HYDROTHERMAL HEAT-FLUX FROM HEAT-FLOW AND DEPTHS OF MIDOCEAN RIDGE SEISMICITY AND MAGMA CHAMBERS

      Geophysical research letters
    94. PEREZ JR; LI YL; STEIN CA; MAJUMDER S; VANOORSCHOT A; NARAYANAN R
      SEQUENCE-INDEPENDENT INDUCTION OF SP1 TRANSCRIPTION FACTOR ACTIVITY BY PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES

      Proceedings of the National Academy of Sciences of the United Statesof America
    95. BISHOP WP; WEN JT; STEIN CA; KRIEG AM
      INHIBITION OF CACO-2 CELL-PROLIFERATION BY CHOLESTEROL-TAGGED ANTISENSE TGF-ALPHA OLIGONUCLEOTIDES AND BY EGF RECEPTOR BLOCKADE

      Gastroenterology
    96. STEIN CA; CULLEN BC
      SATELLITE IMAGERY AND ARCHAEOLOGY - A CASE-STUDY FROM NIKOPOLIS

      American journal of archaeology
    97. TONKINSON JL; STEIN CA
      ANTISENSE NUCLEIC-ACIDS - PROSPECTS FOR ANTIVIRAL INTERVENTION

      Antiviral chemistry & chemotherapy
    98. STEIN CA; TONKINSON J; KHALED Z; ZHANG LM; NELSON N
      CELLULAR PHARMACOLOGY OF OLIGODEOXYNUCLEOTIDES IN HL-60 CELLS

      Journal of cellular biochemistry
    99. SHOBERG T; STEIN CA; STEIN S
      CONSTRAINTS ON LITHOSPHERIC THERMAL STRUCTURE FOR THE INDIAN-OCEAN FROM DEPTH AND HEAT-FLOW DATA

      Geophysical research letters
    100. STEIN CA; CHENG YC
      ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - IS THE BULLET REALLY MAGICAL

      Science


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 15:29:41